centers aim screen 3,000 healthy senior citizens identify 1,000 amyloid positive individuals receive drug therapy alzheimer called solanezumab placebo years anybody slides pet scanner participants prescreened mood depression anxiety ensure capable handling uncertainty potentially construed bad news learn amyloid positive imaging karlawish says people not frankly allowed forward luck trial results not expected 2018 confirm solanezumab viable treatment future help doctors decide makes sense early look alzheimer today article originally published title scanning alzheimer scientific american 309 6 30 31 december 2013 doi:10.1038 scientificamerican1213 30 freelance writer based santa cruz California articles appeared publications 4 hours ago robin lloyd |